Company intelligence / Profile preview

Legacy Pharmaceuticals

Ownership: Private
Development stage: Commercial

Overview

The U.S. and Indian companies distribute and market a portfolio of established pharmaceutical products that are already approved and commercialized in their respective markets. The Swiss CMO was liquidated after bankruptcy in 2021.

Therapeutic areas: PulmonologyOtherDermatologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: small moleculesgeneric drugsestablished prescription pharmaceuticals
Industry: Biotech

Drug pipeline

2 assets

sotalol

Commercial

Indications: Ventricular arrhythmia, Atrial fibrillation, Atrial flutter

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Legacy Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Legacy Pharmaceuticals.

Explore the full profile